Thales Papagiannakopoulos, Ph.D. - Publications

Affiliations: 
2010 Molecular, Cellular & Developmental Biology University of California, Santa Barbara, Santa Barbara, CA, United States 

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wu L, Hollinshead KER, Hao Y, Au C, Kroehling L, Ng C, Lin WY, Li D, Silva HM, Shin J, Lafaille JJ, Possemato R, Pacold ME, Papagiannakopoulos T, Kimmelman AC, et al. Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy. Cell. PMID 32615085 DOI: 10.1016/J.Cell.2020.06.014  0.303
2020 Okazaki K, Papagiannakopoulos T, Motohashi H. Metabolic features of cancer cells in NRF2 addiction status. Biophysical Reviews. PMID 32112372 DOI: 10.1007/S12551-020-00659-8  0.38
2020 Ciampricotti M, Karakousi T, Villalonga AQ, Allaj V, Ventura A, Sen T, Poirier J, Papagiannakopoulos T, Rudin CM. Abstract 420: Rlf-Mycl1 gene fusion as a novel oncogenic driver in a mouse model of small cell lung cancer Cancer Research. 80: 420-420. DOI: 10.1158/1538-7445.Am2020-420  0.394
2019 LeBoeuf SE, Wu WL, Karakousi TR, Karadal B, Jackson SR, Davidson SM, Wong KK, Koralov SB, Sayin VI, Papagiannakopoulos T. Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino Acids. Cell Metabolism. PMID 31813821 DOI: 10.1016/J.Cmet.2019.11.012  0.398
2019 Li F, Huang Q, Luster TA, Hu H, Zhang H, Ng WL, Khodadadi-Jamayran A, Wang W, Chen T, Deng J, Ranieri M, Fang Z, Pyon V, Dowling CM, Bagdatlioglu E, ... ... Papagiannakopoulos T, et al. In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma. Cancer Discovery. PMID 31744829 DOI: 10.1158/2159-8290.Cd-19-0780  0.358
2019 Sayin VI, LeBoeuf SE, Papagiannakopoulos T. Targeting Metabolic Bottlenecks in Lung Cancer. Trends in Cancer. 5: 457-459. PMID 31421901 DOI: 10.1016/J.Trecan.2019.06.001  0.392
2019 Lignitto L, LeBoeuf SE, Homer H, Jiang S, Askenazi M, Karakousi TR, Pass HI, Bhutkar AJ, Tsirigos A, Ueberheide B, Sayin VI, Papagiannakopoulos T, Pagano M. Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1. Cell. PMID 31257023 DOI: 10.1016/J.Cell.2019.06.003  0.379
2019 McLoughlin MR, Orlicky DJ, Prigge JR, Krishna P, Talago EA, Cavigli IR, Eriksson S, Miller CG, Kundert JA, Sayin VI, Sabol RA, Heinemann J, Brandenberger LO, Iverson SV, Bothner B, ... Papagiannakopoulos T, et al. TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy. Proceedings of the National Academy of Sciences of the United States of America. PMID 31097586 DOI: 10.1073/Pnas.1903244116  0.328
2019 Hamza B, Ng SR, Prakadan SM, Delgado FF, Chin CR, King EM, Yang LF, Davidson SM, DeGouveia KL, Cermak N, Navia AW, Winter PS, Drake RS, Tammela T, Li CM, ... Papagiannakopoulos T, et al. Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 30674677 DOI: 10.1073/Pnas.1814102116  0.323
2018 Garcia-Bermudez J, Baudrier L, La K, Zhu XG, Fidelin J, Sviderskiy VO, Papagiannakopoulos T, Molina H, Snuderl M, Lewis CA, Possemato RL, Birsoy K. Publisher Correction: Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nature Cell Biology. PMID 30089842 DOI: 10.1038/S41556-018-0184-2  0.302
2018 Garcia-Bermudez J, Baudrier L, La K, Zhu XG, Fidelin J, Sviderskiy VO, Papagiannakopoulos T, Molina H, Snuderl M, Lewis CA, Possemato RL, Birsoy K. Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nature Cell Biology. PMID 29941933 DOI: 10.1038/S41556-018-0118-Z  0.369
2018 Romero R, Sayin VI, Shawn DM, Bauer M, Singh SX, LeBoeuf S, Karakousi TR, Ellis DC, Bhutkar A, Sanchez-Rivera F, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, ... ... Papagiannakopoulos T, et al. Abstract A43: Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities Cancer Research. 78. DOI: 10.1158/1538-7445.Mousemodels17-A43  0.41
2018 Alvarez SW, Sviderskiy VO, Terzi EM, Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K, Possemato RL. Abstract NG02: NFS1 undergoes positive selection in lung tumors and protects cells from ferroptosis Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ng02  0.4
2017 Alvarez SW, Sviderskiy VO, Terzi EM, Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K, Possemato R. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. PMID 29168506 DOI: 10.1038/Nature24637  0.362
2017 Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, Karakousi TR, Ellis DC, Bhutkar A, Sánchez-Rivera FJ, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, ... ... Papagiannakopoulos T, et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nature Medicine. PMID 28967920 DOI: 10.1038/Nm.4407  0.409
2017 Sayin VI, LeBoeuf SE, Singh SX, Davidson SM, Biancur D, Guzelhan BS, Alvarez SW, Wu WL, Karakousi TR, Zavitsanou AM, Ubriaco J, Muir A, Karagiannis D, Morris PJ, Thomas CJ, ... ... Papagiannakopoulos T, et al. Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer. Elife. 6. PMID 28967864 DOI: 10.7554/Elife.28083  0.375
2016 Ashouri A, Sayin VI, Van den Eynden J, Singh SX, Papagiannakopoulos T, Larsson E. Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events. Nature Communications. 7: 13197. PMID 28959951 DOI: 10.1038/Ncomms13197  0.325
2016 Mayers JR, Torrence ME, Danai LV, Papagiannakopoulos T, Davidson SM, Bauer MR, Lau AN, Ji BW, Dixit PD, Hosios AM, Muir A, Chin CR, Freinkman E, Jacks T, Wolpin BM, et al. Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers. Science (New York, N.Y.). 353: 1161-5. PMID 27609895 DOI: 10.1126/Science.Aaf5171  0.408
2016 Papagiannakopoulos T, Bauer MR, Davidson SM, Heimann M, Subbaraj L, Bhutkar A, Bartlebaugh J, Vander Heiden MG, Jacks T. Circadian Rhythm Disruption Promotes Lung Tumorigenesis. Cell Metabolism. PMID 27476975 DOI: 10.1016/J.Cmet.2016.07.001  0.407
2016 Masri S, Papagiannakopoulos T, Kinouchi K, Liu Y, Cervantes M, Baldi P, Jacks T, Sassone-Corsi P. Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis. Cell. 165: 896-909. PMID 27153497 DOI: 10.1016/J.Cell.2016.04.039  0.341
2016 Sayin VI, Papagiannakopoulos T. Application of CRISPR-mediated genome engineering in cancer research. Cancer Letters. PMID 27000990 DOI: 10.1016/J.Canlet.2016.03.029  0.335
2016 Davidson SM, Papagiannakopoulos T, Olenchock BA, Heyman JE, Keibler MA, Luengo A, Bauer MR, Jha AK, O'Brien JP, Pierce KA, Gui DY, Sullivan LB, Wasylenko TM, Subbaraj L, Chin CR, et al. Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer. Cell Metabolism. PMID 26853747 DOI: 10.1016/J.Cmet.2016.01.007  0.383
2016 Mayers JR, Torrence ME, Davidson SM, Papagiannakopoulos T, Lau AN, Jacks T, Heiden MGV. Abstract PR11: Tissue-of-origin dictates the metabolic fate of branched chain amino acids in mutant Kras-driven cancers Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-Pr11  0.406
2014 Sánchez-Rivera FJ, Papagiannakopoulos T, Romero R, Tammela T, Bauer MR, Bhutkar A, Joshi NS, Subbaraj L, Bronson RT, Xue W, Jacks T. Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature. 516: 428-31. PMID 25337879 DOI: 10.1038/Nature13906  0.384
2014 Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, Fiske BP, Yuan C, Bao Y, Townsend MK, Tworoger SS, Davidson SM, Papagiannakopoulos T, Yang A, Dayton TL, Ogino S, et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nature Medicine. 20: 1193-8. PMID 25261994 DOI: 10.1038/Nm.3686  0.302
2014 Xue W, Chen S, Yin H, Tammela T, Papagiannakopoulos T, Joshi NS, Cai W, Yang G, Bronson R, Crowley DG, Zhang F, Anderson DG, Sharp PA, Jacks T. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature. 514: 380-4. PMID 25119044 DOI: 10.1038/Nature13589  0.324
2014 McFadden DG, Papagiannakopoulos T, Taylor-Weiner A, Stewart C, Carter SL, Cibulskis K, Bhutkar A, McKenna A, Dooley A, Vernon A, Sougnez C, Malstrom S, Heimann M, Park J, Chen F, et al. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell. 156: 1298-311. PMID 24630729 DOI: 10.1016/J.Cell.2014.02.031  0.375
2014 Carter SL, Brastianos PK, McFadden DG, Papagiannakopoulos T, Taylor-Weiner A, Cibulskis K, Jacks T, Hahn W, Getz G. Abstract 3992: Modes of metastasis evolution in human and murine cancer revealed by whole exome sequencing Cancer Research. 74: 3992-3992. DOI: 10.1158/1538-7445.Am2014-3992  0.386
2013 McFadden DG, Papagiannakopoulos T, Cibulskis K, Stewart C, Carter S, Taylor-Weiner A, Bhutkar A, Sougnez C, Dooley A, Shefler E, Lander E, Gabriel S, Getz G, Jacks T. Abstract 1084: Comprehensive genomic analysis of murine small cell lung carcinoma uncovers recurrent Pten alterations that drive tumor progression and alter tumor genome evolution. Cancer Research. 73: 1084-1084. DOI: 10.1158/1538-7445.Am2013-1084  0.393
2012 Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch DH, Barres BA, Verma IM, Kosik KS. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene. 31: 1884-95. PMID 21874051 DOI: 10.1038/Onc.2011.380  0.558
2009 Papagiannakopoulos T, Kosik KS. MicroRNA-124: micromanager of neurogenesis. Cell Stem Cell. 4: 375-6. PMID 19427286 DOI: 10.1016/J.Stem.2009.04.007  0.49
2009 Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 137: 647-58. PMID 19409607 DOI: 10.1016/J.Cell.2009.02.038  0.526
2009 Carrettiero DC, Hernandez I, Neveu P, Papagiannakopoulos T, Kosik KS. The cochaperone BAG2 sweeps paired helical filament- insoluble tau from the microtubule. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 2151-61. PMID 19228967 DOI: 10.1523/Jneurosci.4660-08.2009  0.451
2008 Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Research. 68: 8164-72. PMID 18829576 DOI: 10.1158/0008-5472.Can-08-1305  0.554
2008 Papagiannakopoulos T, Kosik KS. MicroRNAs: regulators of oncogenesis and stemness. Bmc Medicine. 6: 15. PMID 18577221 DOI: 10.1186/1741-7015-6-15  0.544
2007 Liu T, Papagiannakopoulos T, Puskar K, Qi S, Santiago F, Clay W, Lao K, Lee Y, Nelson SF, Kornblum HI, Doyle F, Petzold L, Shraiman B, Kosik KS. Detection of a microRNA signal in an in vivo expression set of mRNAs. Plos One. 2: e804. PMID 17726534 DOI: 10.1371/Journal.Pone.0000804  0.501
Show low-probability matches.